Cannabis-Based Treatment Guide
Chronic pain affects over 50 million Americans and represents the most common reason patients seek medical cannabis. This guide synthesizes current clinical evidence, dosing protocols, and safety considerations to support informed, evidence-based treatment decisions.
Medical Disclaimer: This guide is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before initiating cannabis therapy, especially if taking other medications.
Cannabis exerts analgesic effects through multiple complementary mechanisms, making it particularly effective for complex chronic pain conditions that respond poorly to single-target therapies.
CB1 Receptor Activation
THC binds CB1 receptors in the dorsal horn of the spinal cord and periaqueductal gray, inhibiting pain signal transmission — the same pathway targeted by opioids, but via a distinct receptor system.
CB2 Anti-inflammatory Action
CBD and THC activate CB2 receptors on immune cells, reducing pro-inflammatory cytokine release (TNF-α, IL-6, IL-1β). Particularly effective for inflammatory pain conditions like arthritis.
Endocannabinoid Tone Enhancement
CBD inhibits FAAH enzyme, increasing endogenous anandamide levels. This "endocannabinoid tone" enhancement produces analgesic effects without direct receptor binding.
TRPV1 Modulation
Both THC and CBD modulate TRPV1 (vanilloid) receptors involved in heat and pain perception, contributing to relief from burning neuropathic pain.
Opioid System Interaction
Cannabinoids potentiate opioid analgesia via receptor cross-talk, enabling lower opioid doses for equivalent pain relief — a critical benefit given the opioid crisis.
Chronic pain has the strongest evidence base of any cannabis indication. Multiple meta-analyses and systematic reviews support efficacy for neuropathic pain specifically.
8+
Meta-Analyses
79+
RCTs Reviewed
6,400+
Patients Studied